Corynebacterium parvum as an immunotherapeutic anticancer agent.
D000818:Animals; D002330:Carmustine / Q000627:therapeutic use; D003352:Corynebacterium / Q000276:immunology; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007167:Immunotherapy; D037102:Lectins / Q000494:pharmacology; D008113:Liver Neoplasms / Q000628:therapy; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental; D011425:Propionibacterium acnes / Q000276:immunology*; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology
D037102:Lectins; D002330:Carmustine